Ada L.
About Ada L.
Ada L. is a Cell Therapy Specialist II at Kite Pharma, where she has worked since 2021. She holds a Bachelor of Science from UC Irvine and a Bachelor of Arts from Can Tho University, as well as a Master's degree from the University of Southern California.
Work at Kite Pharma
Currently, Ada L. serves as a Cell Therapy Specialist II at Kite Pharma, a role she has held since 2021. In this position, she is involved in the development and implementation of cell therapy solutions. Kite Pharma focuses on innovative cancer therapies, particularly in the field of CAR T-cell therapy. Ada's expertise contributes to the advancement of these therapies, aimed at improving patient outcomes.
Education and Expertise
Ada L. holds a Bachelor of Science (BS) degree from the University of California, Irvine, where she studied from 2012 to 2015. Additionally, she earned a Bachelor of Arts (B.A.) from Can Tho University, School of Education, completing her studies from 2004 to 2008. Furthering her education, Ada obtained a Master's degree from the University of Southern California - Marshall School of Business, studying from 2021 to 2023. Her diverse educational background equips her with a strong foundation in both scientific and business principles.
Background
Ada L. has a multifaceted educational background that spans several years and institutions. She began her higher education at Can Tho University, where she completed her Bachelor of Arts degree. Following this, she pursued a Bachelor of Science degree at UC Irvine. Most recently, she expanded her qualifications with a Master's degree from USC. This combination of degrees reflects her commitment to both education and professional development in the fields of science and business.
Professional Experience
In her role as a Cell Therapy Specialist II at Kite Pharma, Ada L. has accumulated significant experience in the field of cell therapy over the past three years. Her responsibilities likely include working on the development of therapeutic protocols and collaborating with multidisciplinary teams to enhance treatment methodologies. This experience positions her as a knowledgeable professional in the rapidly evolving landscape of cancer treatment.